Ambev S.A. Files June 2024 6-K Report

TL;DR

Ambev S.A. (ABEV) filed its monthly 6-K report, confirming its status as a foreign private issuer and its use of Form 20-F for annual reports.

AI Summary

Ambev S.A. filed a Form 6-K on June 11, 2024, for the month of June 2024. The filing is a report of a foreign private issuer and indicates that Ambev S.A. files annual reports under Form 20-F. The company's principal executive office is located in Sao Paulo, Brazil.

Why It Matters

This filing provides routine updates for Ambev S.A., a major beverage company, informing investors and the market about its ongoing compliance and reporting status as a foreign private issuer.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial information or significant corporate events.

Key Players & Entities

• Ambev S.A. (company) — Registrant
• 0001292814-24-002366 (accession_number) — Filing identifier
• 20240611 (date) — Filing date
• June 2024 (date) — Reporting period
• Sao Paulo, Brazil (location) — Principal executive office location
• Form 20-F (document_type) — Annual report form
• Form 6-K (document_type) — Report type

FAQ

Filing Documents

• abevcvm358may2024_6k.htm (6-K) — 71KB
• 0001292814-24-002366.txt ( ) — 72KB

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of June, 2024 Commission File Number 1565025 AMBEV S.A. (Exact name of registrant as specified in its charter) AMBEV S.A. (Translation of Registrant's name into English) Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor 04530-000 São Paulo, SP Federative Republic of Brazil (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ___X___ Form 40-F _______ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes _______ No ___X____ INDIVIDUAL FORM Article 11 - CVM Instruction # 358/2002 In May 2024: (X) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1) ( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows. Company Name: Ambev S.A. Name: Ambev S.A. CPF/CNPJ: 07.526.557/0001-00 Qualification: Outstanding Shares in Treasury Initial Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 7,474,632 ADR Common 0,00 Transactions in the month Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3) Shares Common UBS Corretora Buy 21 5,000 12.10 60,500.00 Shares Common UBS Corretora Buy 21 5,000 12.11 60,550.00 Shares Common UBS Corretora Buy 21 130,000 12.13 1,576,900.00 Shares Common UBS Corretora Buy 21 348,200 12.14 4,227,148.00 Shares Common UBS Corretora Buy 21 3,411,800 12.15 41,453,370.00 Shares Common UBS Corretora Buy 21 200,000 12.17 2,434,000.00 Shares Common UBS Corretora Buy 21 69,200 12.18 842,856.00 Shares Common UBS Corretora Buy 21 150,000 12.19 1,828,500.00 Shares Common UBS Corretora Buy 21 680,800 12.20 8,305,760.00 Shares Common UBS Corretora Buy 22 1,911,200 11.95 22,838,840.00 Shares Common UBS Corretora Buy 22 25,000 12.02 300,500.00 Shares Common UBS Corretora Buy 22 75,000 12.03 902,250.00 Shares Common UBS Corretora Buy 22 725,000 12.04 8,729,000.00 Shares Common UBS Corretora Buy 22 2,400,000 12.05 28,920,000.00 Shares Common UBS Corretora Buy 22 851,500 12.06 10,269,090.00 Shares Common UBS Corretora Buy 22 173,500 12.07 2,094,145.00 Shares Common UBS Corretora Buy 22 410,400 12.08 4,957,632.00 Shares Common UBS Corretora Buy 22 312,300 12.09 3,775,707.00 Shares Common UBS Corretora Buy 22 27,300 12.10 330,330.00 Shares Common UBS Corretora Buy 23 130,100 11.95 1,554,695.00 Shares Common UBS Corretora Buy 23 62,600 11.96 748,696.00 Shares Common UBS Corretora Buy 23 703,000 11.97 8,414,910.00 Shares Common UBS Corretora Buy 23 985,600 11.98 11,807,488.00 Shares Common UBS Corretora Buy 23 1,225,900 11.99 14,698,541.00 Shares Common UBS Corretora Buy 23 1,892,800 12.00 22,713,600.00 Shares Common UBS Corretora Buy 24 2,021,600 11.90 24,057,040.00 Shares Common UBS Corretora Buy 24 67,200 11.91 800,352.00 Shares Common UBS Corretora Buy 24 699,500 11.92 8,338,040.00 Shares Common UBS Corretora Buy 24 1,500,000 11.93 17,895,000.00 Shares Common UBS Corretora Buy 24 1,050,500 11.94 12,542,970.00 Shares Common UBS Corretora Buy 24 1,750,000 11.95 20,912,500.00 Final Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 31,474,632 ADR Common 0,00 (1) When filling in the form, delete the lines that do not have any information, If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information, (2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others, (3) Quantity multiplied by price, (*) Each ADR is equivalent to 1 (one) share, SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: June 10, 2024 AMBEV S.A. By: /s/ Lucas Machado Lira Lucas Machado Lira Chief Financial and Investor Relations Officer

View Full Filing

View this 6-K filing on SEC EDGAR